Staphylococcal Infections: Clinical Trials

4 trials for Staphylococcal Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 4
Phase 21Terminated 1

Follow Staphylococcal Infections: new trials by email Literature Review of Staphylococcal Infections trials Research Report on Staphylococcal Infections

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
Suvratoxumab, Placebo - Ventilator Associated Pneumonia, Staphylococcus Aureus
Phase 3TerminatedAridis Pharmaceuticals, Inc.242022-09-022025-03-24
A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
Telavancin, Vancomycin, Daptomycin - Bacteremia
Phase 3TerminatedCumberland Pharmaceuticals1212014-12-012020-02-17
Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)
V710, Placebo - Staphylococcus Aureus, Bacteremia
Phase 2 / Phase 3TerminatedMerck Sharp & Dohme LLC80312007-12-012015-10-02
Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease
Staph aureus types 5 and 8 conjugate vaccine, placebo - Staphylococcal Infections, Chronic Kidney Failure
Phase 3TerminatedNabi Biopharmaceuticals992005-08-012008-01-04

Narrower conditions

Bacteremia (2)  ·  Kidney Failure, Chronic (1)  ·  Mediastinitis (1)  ·  Pneumonia, Ventilator-Associated (1)

Broader conditions

Bacterial Infections (4)  ·  Bacterial Infections and Mycoses (4)  ·  Gram-Positive Bacterial Infections (4)  ·  Infections (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Disease Attributes (2)  ·  Inflammation (2)  ·  Respiratory Tract Diseases (2)  ·  Sepsis (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Chronic Disease (1)  ·  Cross Infection (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

Cefazolin (1)  ·  Cloxacillin (1)  ·  Daptomycin (1)  ·  Nafcillin (1)  ·  Oxacillin (1)  ·  StaphVax (1)  ·  V710 vaccine (1)  ·  Vancomycin (1)  ·  suvratoxumab (1)  ·  telavancin (1)

Sponsors

Aridis Pharmaceuticals, Inc. (1)  ·  Cumberland Pharmaceuticals (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Nabi Biopharmaceuticals (1)

Countries

United States (2)  ·  Belgium (1)  ·  France (1)  ·  Greece (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Spain (1)

Top investigators

Matt Hohenboken, MD, PhD (1)

Results publications

PMID 23549582